Letter from the Editor EditorDr Stefan Rauh, Centre Hospitalier Emile Mayrisch, Esch, Luxembourg ConferenceBCC 2019 21 May, 2019 22:56
New Prognostic Biomarkers for Survival Breast Cancer Presented ByDr Jasmin Zeindler, University Hospital Basel, Switzerland ConferenceBCC 2019 21 May, 2019 22:53
Adjuvant chemotherapy after neoadjuvant chemotherapy? Going beyond EMA/FDA TrialKATHERINE, CREATE-X ConferenceBCC 2019 21 May, 2019 16:29
Endocrine therapy in postmenopausal patients: a graded approach ConferenceBCC 2019 21 May, 2019 14:32
Adjuvant Her2-targeted therapy TrialAPHINITY Conference10:31:46pm> hello nurse from conference 21 May, 2019 13:35
Extrapolating data from clinical trials as we treat patients in real life Presented ByProf. Sharon Giordano, MD Anderson, Houston, USA TrialAPHINITY, KATHERINE, ExteNET ConferenceBCC 2019 21 May, 2019 23:44
What is the clinical benefit of treatment of patients with early breast cancer? Presented ByProf. Ann Partridge, Dana-Farber Cancer Institute, Boston, USA ConferenceBCC 2019 21 May, 2019 22:47
Adjuvant and neoadjuvant therapy: principles and practical considerations Presented ByProf. Eric Winer, Dana-Farber Cancer Institute, Boston, USA TrialNSABP B-18, NSABP B-27, ACOSOG Z1071, NEO-ALTTO, APHINITY, I-SPY2 ConferenceBCC 2019 21 May, 2019 09:49
Discordance of biomarkers in multifocal and lymph node positive breast cancer Presented ByDr Marie Sundquist, Kalmar County Hospital, Sweden ConferenceBCC 2019 21 May, 2019 23:51
New Prognostic Biomarkers for Survival Breast Cancer Presented ByDr Jasmin Zeindler, University Hospital Basel, Switzerland ConferenceBCC 2019 21 May, 2019 22:53
Selection of patients for neoadjuvant chemotherapy treatment based on oncotype recurrence score in luminal breast cancer Presented ByDr Ariadna Gasol Cudos, Hospital Universitari Arnau de Vilanova de Lleida, Spain ConferenceBCC 2019 21 May, 2019 09:55